Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.
- 2025-10-06
- RCT
- BMC complementary medicine and therapies 25(1)
- Panithan Tuntiyatorn
- Chawanin Lerspongpaibool
- Thepparat Kanchanathepsak
- Ittirat Watcharananan
- Tulyapruek Tawonsawatruk
- PubMed: 41053771
- DOI: 10.1186/s12906-025-05096-2
- High evidence
- Clinical
Although patients in the curcumin group showed reductions in VAS pain scores and improvements in DASH scores after one month, the differences were not statistically significant.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 170 mg/day